Clinical Trial Update: Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial update for anisodine hydrobromide as preventive treatment for episodic migraine (with and without aura) is in progress, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Anisodine Hydrobromide (anisodine hydrobromide)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Migraine Without Aura, Migraine With Aura | Phase 3 | Status: UNKNOWN